BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16985618)

  • 1. Urothelial carcinoma in a man with hereditary nonpolyposis colon cancer.
    Lenz DL; Harpster LE
    Rev Urol; 2003; 5(1):49-53. PubMed ID: 16985618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary nonpolyposis colorectal cancer syndrome in a patient with urothelial carcinoma of the upper urothelial tract.
    Hartmann A; Cheville JC; Dietmaier W; Hofstädter F; Burgart LJ; Blaszyk H
    Arch Pathol Lab Med; 2003 Feb; 127(2):E60-3. PubMed ID: 12562253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum.
    Rouprêt M; Yates DR; Comperat E; Cussenot O
    Eur Urol; 2008 Dec; 54(6):1226-36. PubMed ID: 18715695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lynch Syndrome: A Primer for Urologists and Panel Recommendations.
    Mork M; Hubosky SG; Rouprêt M; Margulis V; Raman J; Lotan Y; O'Brien T; You N; Shariat SF; Matin SF
    J Urol; 2015 Jul; 194(1):21-9. PubMed ID: 25711197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool.
    Audenet F; Colin P; Yates DR; Ouzzane A; Pignot G; Long JA; Soulie M; Phé V; Bensadoun H; Guy L; Ruffion A; Valeri A; Cormier L; Droupy S; de La Taille A; Saint F; Faïs PO; Houlgatte A; Cussenot O; Rouprêt M;
    BJU Int; 2012 Dec; 110(11 Pt B):E583-9. PubMed ID: 22703159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
    Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
    Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Urinalysis-Based Screening for Urothelial Carcinoma in Patients With Lynch Syndrome.
    Chouhan H; Abbass MA; Hrabe JE; Ferrandon S; DeVecchio J; Mankaney G; Burke CA; Heald B; Ann LaGuardia L; O'Malley M; Milicia S; Liska D; Church J; Campbell SC; Kalady MF
    Dis Colon Rectum; 2022 Jan; 65(1):40-45. PubMed ID: 34882627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upper tract urothelial carcinomas: frequency of association with mismatch repair protein loss and lynch syndrome.
    Harper HL; McKenney JK; Heald B; Stephenson A; Campbell SC; Plesec T; Magi-Galluzzi C
    Mod Pathol; 2017 Jan; 30(1):146-156. PubMed ID: 27713421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upper tract urothelial carcinoma: a clinicopathologic study including microsatellite instability analysis.
    Blaszyk H; Wang L; Dietmaier W; Hofstädter F; Burgart LJ; Cheville JC; Hartmann A
    Mod Pathol; 2002 Aug; 15(8):790-7. PubMed ID: 12181263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological characteristics of patients with upper urinary tract urothelial cancer with loss of immunohistochemical expression of the DNA mismatch repair proteins in universal screening.
    Urakami S; Inoshita N; Oka S; Miyama Y; Nomura S; Arai M; Sakaguchi K; Kurosawa K; Okaneya T
    Int J Urol; 2018 Feb; 25(2):151-156. PubMed ID: 29164703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germ line mutations of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients with small bowel cancer: International Society for Gastrointestinal Hereditary Tumours Collaborative Study.
    Park JG; Kim DW; Hong CW; Nam BH; Shin YK; Hong SH; Kim IJ; Lim SB; Aronson M; Bisgaard ML; Brown GJ; Burn J; Chow E; Conrad P; Douglas F; Dunlop M; Ford J; Greenblatt MS; Heikki J; Heinimann K; Lynch EL; Macrae F; McKinnon WC; Möeslein G; Rossi BM; Rozen P; Schofield L; Vaccaro C; Vasen H; Velthuizen M; Viel A; Wijnen J;
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3389-93. PubMed ID: 16740762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hereditary nonpolyposis colorectal carcinoma (HNPCC). Current review of etiology, clinical aspects, diagnosis and therapy].
    al-Taie O; Mörk H; Seufert J; Treis H; Jakob F; Scheurlen M
    Med Klin (Munich); 2001 Sep; 96(9):529-38. PubMed ID: 11603116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of molecular alterations in colorectal, upper urinary tract, endocervical, and renal carcinomas arising in a patient with hereditary non-polyposis colorectal cancer.
    Mongiat-Artus P; Miquel C; Fléjou JF; Coulet F; Verine J; Buhard O; Soliman H; Teillac P; Praz F
    Virchows Arch; 2006 Aug; 449(2):238-43. PubMed ID: 16639607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Molecular cancer disposition diagnosis exemplified by colorectal carcinoma. What is the contribution of pathology?].
    Rüschoff J; Dietmaier W; Bocker T; Wallinger S; Kullmann F; Beham A; Hofstädter F
    Pathologe; 1998 Jul; 19(4):269-78. PubMed ID: 9746911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is hereditary nonpolyposis colorectal cancer (HNPCC).
    Vasen HF
    Anticancer Res; 1994; 14(4B):1613-5. PubMed ID: 7979195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Universal Point of Care Testing for Lynch Syndrome in Patients with Upper Tract Urothelial Carcinoma.
    Metcalfe MJ; Petros FG; Rao P; Mork ME; Xiao L; Broaddus RR; Matin SF
    J Urol; 2018 Jan; 199(1):60-65. PubMed ID: 28797715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer.
    Müller A; Edmonston TB; Corao DA; Rose DG; Palazzo JP; Becker H; Fry RD; Rueschoff J; Fishel R
    Cancer Res; 2002 Feb; 62(4):1014-9. PubMed ID: 11861375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Lynch syndrome among patients with upper urinary tract carcinoma in a Japanese hospital-based population.
    Ito T; Kono K; Eguchi H; Okazaki Y; Yamamoto G; Tachikawa T; Akagi K; Okada Y; Kawakami S; Morozumi M; Tamaru JI; Ishida H
    Jpn J Clin Oncol; 2020 Jan; 50(1):80-88. PubMed ID: 31665498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
    Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
    Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors-A Cohort Study.
    Aswath K; Welch J; Gubbi S; Veeraraghavan P; Avadhanula S; Gara SK; Dikoglu E; Merino M; Raffeld M; Xi L; Kebebew E; Klubo-Gwiezdzinska J
    Front Endocrinol (Lausanne); 2021; 12():653401. PubMed ID: 34326811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.